William B. Horne, Director at Alzamend Neuro, Inc. (ALZN), bought 15,000 shares at $0.97 ($5K) on 2025-03-18, disclosed to the SEC on 2025-03-19.
Open-market purchase of $5k ALZN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.06 | 10,000 | $600 | 11.0% |
| 2 | $0.97 | 5,000 | $5K | 89.0% |
| Total | $0.36 avg | 15,000 | $5K | 100% |
| Filing → |
| GPUS | BUY | 2026-09-18 | $18K | — | Filing → |
| GPUS | BUY | 2026-09-08 | $31K | — | Filing → |
| GPUS | BUY | 2026-09-02 | $20K | — | Filing → |